首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   79篇
  免费   6篇
林业   1篇
  3篇
综合类   2篇
水产渔业   1篇
畜牧兽医   77篇
植物保护   1篇
  2022年   2篇
  2019年   1篇
  2018年   4篇
  2017年   1篇
  2016年   1篇
  2015年   1篇
  2014年   1篇
  2013年   6篇
  2012年   5篇
  2011年   4篇
  2010年   5篇
  2009年   3篇
  2008年   8篇
  2007年   5篇
  2006年   4篇
  2005年   3篇
  2004年   2篇
  2003年   1篇
  2001年   2篇
  2000年   2篇
  1999年   1篇
  1998年   1篇
  1997年   1篇
  1992年   2篇
  1991年   2篇
  1989年   1篇
  1988年   1篇
  1985年   1篇
  1981年   1篇
  1980年   1篇
  1979年   1篇
  1978年   1篇
  1972年   1篇
  1971年   5篇
  1970年   2篇
  1968年   2篇
排序方式: 共有85条查询结果,搜索用时 15 毫秒
71.
Gene therapy approaches to the treatment of HIV infection have targeted both viral gene expression and the cellular factors that are essential for virus replication. However, significant concerns have been raised regarding the potential toxic effects of such therapies, the emergence of resistant viral variants and unforeseen biological consequences such as enhanced susceptibility to unrelated pathogens. Novel restriction factors formed by the fusion of the tripartite motif protein (TRIM5) and cyclophilin A (CypA), or "TRIMCyps", offer an effective antiviral defence strategy with a very low potential for toxicity. In order to investigate the potential therapeutic utility of TRIMCyps in gene therapy for AIDS, a synthetic fusion protein between feline TRIM5 and feline CypA was generated and transduced into cells susceptible to infection with feline immunodeficiency virus (FIV). The synthetic feline TRIMCyp was highly efficient at preventing infection with both HIV and FIV and the cells resisted productive infection with FIV from either the domestic cat or the puma. Feline TRIMCyp and FIV infection of the cat offers a unique opportunity to evaluate TRIMCyp-based approaches to genetic therapy for HIV infection and the treatment of AIDS.  相似文献   
72.
73.
74.
Background: English Bulldogs (EB) with pulmonic stenosis (PS) sometimes have an aberrant coronary artery (CA) type R2A encircling the pulmonary artery (PA). Balloon valvuloplasty (BV) is treatment of choice for severe PS, but is considered to be contraindicated in dogs with aberrant CA. Hypothesis: Conservative BV in EB with aberrant CA is safe and improves clinical signs and quality of life. Animals: Four client‐owned EB with severe PS were retrospectively reviewed/analysed. Methods: Retrospective study: Case records, echocardiography, BV, and follow‐up investigations of EB diagnosed with severe PS and treated with BV were reviewed. The ratios of PA to aortic (Ao) velocity time integral (VTI) were calculated to assess progression/improvement of PS. Results: An aberrant CA was confirmed on angiography in all EB. Conservative BV was performed, using a balloon of the size of the PA annulus or smaller (0.6–1 × PA annulus size). All dogs survived the procedure, but only a mild reduction in pressure gradient was achieved. There was an improvement in PA to Ao VTI in 3 of 4 dogs (P≤ .017), which were free of evidence of congestive heart failure (CHF) 5, 10, and 15 months after BV. One dog that had right‐sided CHF when BV was performed died due to progressive right‐sided CHF within 3 months. Conclusions: Conservative BV in EB might be safe and might improve quality and quantity of life.  相似文献   
75.
The objective of this systematic review, which was performed following the guidelines of the Cochrane collaboration, was to assess the effects of interventions for treatment of atopic dermatitis (AD) in dogs. Citations identified from three databases (MEDLINE, Thomson's Science Citation Index Expanded and CAB Abstracts) and trials published by December 2007 were selected. Proceedings books from the major veterinary dermatology international congresses were hand searched for relevant citations. The authors selected randomized controlled trials (RCTs), published from January 1980 to December 2007, which reported the efficacy of topical or systemic interventions for treatment or prevention of canine AD. Studies had to report assessments of either pruritus or skin lesions, or both. Studies were selected and data extracted by two reviewers, with discrepancies resolved by a third arbitrator. Missing data were requested from study authors of recently published trials. Pooling of results and meta-analyses were performed for studies reporting similar interventions and outcome measures. A total of 49 RCTs were selected, which had enrolled 2126 dogs. This review found some evidence of efficacy of topical tacrolimus (3 RCTs), topical triamcinolone (1), oral glucocorticoids (5), oral ciclosporin (6), subcutaneous recombinant γ-interferon (1) and subcutaneous allergen-specific immunotherapy (3) to decrease pruritus and/or skin lesions of AD in dogs. One high-quality RCT showed that an oral essential fatty acid supplement could reduce prednisolone consumption by approximately half. Additional RCTs of high design quality must be performed to remedy previous flaws and to test interventions for prevention of flares of this disease.  相似文献   
76.
A QTL affecting leg muscle and fat traits has been identified within the New Zealand Texel population. The QTL maps to a region on OAR 2 with a two-marker haplotype test established at markers BULGE20 and BM81124. These markers encompass the likely position of Growth Differentiation Factor 8 (GDF8). The pleiotropic effects of this QTL on meat quality traits are tested. Objective measures of meat quality including pH, color (L*, a*, and b*), and tenderness (as assessed by Warner-Bratzler shear force measurements) were assessed on longissimus and semi-membranosus muscles of 540 progeny from six Texel sires. Four of these sires were subsequently identified as segregating for leg muscle and fat traits. For these segregating sires, comparison of progeny that had inherited the favorable haplotype from their sire with those that had received the alternate haplotype revealed no significant differences in the meat quality traits assessed. This finding suggests that the muscling QTL does not have pleiotropic effects on meat quality. A general scan for meat quality QTL was carried out using genotype data for eight markers from FCB128 to RM356 flanking 122cM of OAR 2 using Haley-Knott regression. This analysis revealed two QTL for a single sire. A QTL detected in the region of Marker INRA40 for color L* mapped to a site close to the muscling QTL, but there was evidence to suggest it is at a distinct locus. The QTL in the region of Marker RM356 might map distal to Marker RM356, as no peak was observed. This QTL, which seems to affect pH, color a*, color b*, and Warner-Bratzler shear measurements, requires further characterization.  相似文献   
77.
A two-year-old Scottish terrier was referred for investigation of a chronic skin problem. A diagnosis of generalised demodectic mange with a deep pyoderma was made and treatment commenced with trimethoprirn-sulphamethoxazole and amitraz washes. On the sixth week of treatment the owner reported that the dog had developed haematuria. Investigations revealed that the dog was thrombocytopenic and anaemic. Antimicrobial treatment was stopped and the platelet count returned to normal over a three week period. A diagnosis of trimethoprim-sulphamethoxazole associated thrombocytopenia was made.  相似文献   
78.
79.
80.
SUMMARY During the years 1971 to 1980, 355 samples of animal feeds submitted to this laboratory in connection with suspected mycotoxicoses were analysed for aflatoxins. Most major Queensland agricultural crops were represented. Aflatoxins were detected in 67 samples, 45 of which were peanut meals and by-products (55% of all peanut materials analysed). Of 200 Aspergillus flavus isolates cultured on maize meal, aflatoxins were produced by 49%. Ochratoxin A was detected in one sample of another 25 feeds analysed for the compound. Ochratoxin A was produced by 28% of 47 A. ochraceus isolates, and two Fusarium equiseti isolates produced zearalenone. The present situation with regard to mycotoxins and mycotoxicosis in Queensland is briefly reviewed.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号